The Role of Digoxin-specific Antibodies in the Treatment of Digitalis Poisoning
  Overview
        Overview
  Authors
          Authors
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Citing Articles
                              Fab antibody fragments: some applications in clinical toxicology.
Flanagan R, Jones A Drug Saf. 2004; 27(14):1115-33.
PMID: 15554746 DOI: 10.2165/00002018-200427140-00004.
Diagnosis and treatment of digoxin toxicity.
Lip G, Metcalfe M, Dunn F Postgrad Med J. 1993; 69(811):337-9.
PMID: 8346128 PMC: 2399830. DOI: 10.1136/pgmj.69.811.337.
Wood W, Farber P, Kurowski V Klin Wochenschr. 1990; 68(6):324-7.
PMID: 2335903 DOI: 10.1007/BF01649024.
  References
                              1.
  
    Wenger T, Butler Jr V, Haber E, Smith T
    
    . Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. J Am Coll Cardiol. 1985; 5(5 Suppl A):118A-123A.
    
          DOI: 10.1016/s0735-1097(85)80471-x.
    
    View
  
2.
  
    Lloyd B, Smith T
    
    . Contrasting rates of reversal of digoxin toxicity by digoxin-specific IgG and Fab fragments. Circulation. 1978; 58(2):280-3.
    
          DOI: 10.1161/01.cir.58.2.280.
    
    View
  
3.
  
    Smith T
    
    . New advances in the assessment and treatment of digitalis toxicity. J Clin Pharmacol. 1985; 25(7):522-8.
    
          DOI: 10.1177/009127008502500708.
    
    View
  
4.
  
    Butler Jr V, Chen J
    
    . Digoxin-specific antibodies. Proc Natl Acad Sci U S A. 1967; 57(1):71-8.
          PMC: 335466.
    
          DOI: 10.1073/pnas.57.1.71.
    
    View
  
5.
  
    Smith T, Butler Jr V, Haber E, Fozzard H, MARCUS F, Bremner W
    
    . Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med. 1982; 307(22):1357-62.
    
          DOI: 10.1056/NEJM198211253072201.
    
    View